Correction to: Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease ; volume:19 ; number:1 ; day:26 ; month:4 ; year:2021 ; pages:1 ; date:12.2021
Journal of nanobiotechnology ; 19, Heft 1 (26.4.2021), 1, 12.2021
- Creator
-
Karki, Hem Prakash
Jang, Yeongseok
Jung, Jinmu
Oh, Jonghyun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12951-021-00850-3
- URN
-
urn:nbn:de:101:1-2021090420492826323252
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Karki, Hem Prakash
- Jang, Yeongseok
- Jung, Jinmu
- Oh, Jonghyun
- SpringerLink (Online service)
Other Objects (12)
Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease
Advances in Alzheimer’s Disease Drug Development
Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF
Advances in Drug Therapy for Alzheimer’s Disease
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
Advances in the development of new biomarkers for Alzheimer’s disease
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
Advances in Modeling Alzheimer's Disease In Vitro
An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer’s disease
Development of an ultra-sensitive assay for early diagnosis of Alzheimer's disease
Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease
Advances in Alzheimer’s Disease Drug Development
Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF
Advances in Drug Therapy for Alzheimer’s Disease
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
Advances in the development of new biomarkers for Alzheimer’s disease
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
Advances in Modeling Alzheimer's Disease In Vitro
An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer’s disease
Development of an ultra-sensitive assay for early diagnosis of Alzheimer's disease
Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease
Advances in Alzheimer’s Disease Drug Development
Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF
Advances in Drug Therapy for Alzheimer’s Disease
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
Advances in the development of new biomarkers for Alzheimer’s disease
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
Advances in Modeling Alzheimer's Disease In Vitro
An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer’s disease